Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases (Q33811597)

29 July 2017

1 reference

title

Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases (English)

1 reference

29 July 2017

Buxbaum J

1

1 reference

29 July 2017

Gallo G

series ordinal

2

1 reference

29 July 2017

publication date

1 December 1999

1 reference

Hematology / Oncology Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

13

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

1235-1248

1 reference

Brief report: heavy-chain deposition disease

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Light-heavy chain deposition disease progressing to multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Structural peculiarities of a truncated V kappa III immunoglobulin light chain in myeloma with light chain deposition disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Complete primary sequences of two lambda immunoglobulin light chains in myelomas with nonamyloid (Randall-type) light chain deposition disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Molecular modeling of immunoglobulin light chains implicates hydrophobic residues in non-amyloid light chain deposition disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

The Systemic Amyloidoses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

A possible pathogenic mechanism for rhabdomyolysis associated with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Characterization of tissue amyloid by immunofluorescence microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Lambda light chain deposition disease presenting as sicca syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Long-Term Follow-Up and Response to Chemotherapy in Patients With Light-Chain Deposition Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Monoclonal heavy chain (immunoglobulin G3) deposition disease: report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Association light chain deposition disease (LCDD) and amyloidosis. One case

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Amino-terminal identity of co-existent amyloid and non-amyloid immunoglobulin kappa light chain deposits. A human disease to study alterations of protein conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Structure of abnormal heavy chains in human heavy-chain-deposition disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Systemic light chain deposition disease presenting as multiple pulmonary nodules. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Smoldering multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Recurrence of immunoglobulin A-kappa crystalline deposition disease after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Light chain deposition disease presenting with hepatomegaly: an association with amyloid-like fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Manifestations of systemic light chain deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

IgG heavy-chain deposition disease affecting kidney, skin, and skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Simultaneous AL-type amyloid and light chain deposit disease in a liver biopsy: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

Nephrotoxic potential of Bence Jones proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970123-4

7 January 2021

10.1016/S0889-8588(05)70123-4

Identifiers

DOI

1 reference

29 July 2017

1 reference